Skip to main content

Table 2 Quantitative and qualitative variables collected at 6 (M6), 12 (M12), 18 (M18) and 24 (M24) months after alcohol withdrawal

From: A prospective hospital study of alcohol use disorders, comorbid psychiatric conditions and withdrawal prognosis

 

M6

M12

M18

M24

Mean ± SD or  %

N

Mean ± SD or  %

N

Mean ± SD or  %

N

Mean ± SD or  %

N

With any data

51.8

171

38.6

146

42.7

141

51.8

249

With data to assess abstinence

27.6

91

33.9

112

33.9

112

75.5

171

Abstinent

57.1

52

40.2

45

46.4

52

41.4

103

Reasons for the absence of follow-up

 No data—lost

47.8

76

62.4

118

38.8

128

13.3

13

 Impossible to come

24.8

82

34.4

65

15.2

50

19.4

64

 Death

0.03

1

3.2

6

7.3

14

21.4

21

With a psychiatric comorbidity

 56.7

97

 63.7

93

 42.5

77

 48.2

120

Type of psychiatric comorbidity

    

37.7

   

 None

29.9

29

42.0

39

5.19

29

46.7

50

 Dementia

0

0

0

0

15.5

4

0

0

 Psychosis

9.3

9

18.2

17

20.7

12

14.9

16

 Mood disorder

37.1

36

20.4

19

3.9

16

13.1

14

 Anxiety disorder

9.3

9

3.2

3

24.7

3

1.9

2

 Personality disorder

21

18

20.4

19

 

19

15.9

17

With somatic comorbidity

11.3

11

6.5

6

5.2

4

5.6

6

Global Assessment of Functioning

59.9 ± 19.7

70

56.7 ± 20.1

66

59.7 ± 20.6

63

58.2 ± 19.3

88

AUDIT score

 

14.5 ± 12.2

130

 

14.0 ± 12.1

162

 Risk use (score ≤7)

 

36.2

45

 

40.1

65

 Harmful use (7 < score <13)

 

13.1

17

 

6.2

10

 Dependence (score ≥13)

 

50.8

66

 

50.6

82

BDI

8.3 ± 7.3

163

7.8 ± 7.5

133

7.2 ± 7.1

130

7.7 ± 7.3

168

 Absent

29.5

48

39.1

52

36.9

48

40.2

68

 Slight

25.8

42

15.8

21

24.6

32

20.1

34

 Moderate

28.8

47

30.1

40

25.4

33

21.3

36

 Severe

15.9

26

15.0

20

13.1

17

18.3

31

MCV (UI/L)

94.9 ± 6.0

175

95.4 ± 5.9

140

94.4 ± 5.9

141

94.3 ± 6.2

169

 % >normal values (n)

34.9

61

40

56

30.5

43

34.3

58

TGO (UI/L)

 

 

 

39.0 ± 55.3

 

 % >normal values (n)

      

24.6

41

TGP (UI/L)

 

 

 

38.8 ± 61.9

 

 % >normal values (n)

      

29.9

50

GGT (UI/L)

94.9 ± 6.0

175

108.0 ± 269.3

143

112.9 ± 290.8

140

156.0 ± 379.9

168

 % >normal values (n)

43.4

76

40.6

58

41.4

58

18.8

82

Current psychotropic treatment

        

 Neuroleptics

15.3

27

13.3

20

18.0

27

15.0

36

 Atypical antipsychotics

25.0

44

24.6

37

24.0

36

23.0

55

 Thymoregulators

13.6

24

12.0

18

12.0

18

11.3

27

 Antidepressants

63.0)

111

65.3

98

62.6

94

51.8

124

 Anxiolytics

67.0

118

65.3

98

61.3

92

57.3

137

 Benzodiazepines

56.2

99

56.0

84

11.5

38

48.9

116

 Related to benzodiazepines

22.1

39

17.3

26

25.1

83

18.1

43

  1. AUDIT Alcohol Use Disorder Identification Test, BDI Beck Depression Inventory, GGT gamma-glutamyl transferase, MCV mean corpuscular volume, SGOT serum glutamate oxaloacetate transaminase, SGPT serum glutamic pyruvic transaminase